March 13, 2020 / 1:05 PM / 15 days ago

BRIEF-Atossa Therapeutics Announces Upcoming Meeting With FDA

March 13 (Reuters) - Atossa Therapeutics Inc:

* ATOSSA THERAPEUTICS ANNOUNCES UPCOMING MEETING WITH FDA

* ATOSSA GENETICS INC - WILL MEET WITH U.S. FDA ON APRIL 30, 2020

* ATOSSA GENETICS- OBJECTIVE OF MEETING WITH FDA IS TO DISCUSS CLINICAL DEVELOPMENT OF ORAL ENDOXIFEN TO REDUCE MAMMOGRAPHIC BREAST DENSITY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below